We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPBC
901
DELISTED
NATL PENN BANCSHARES INC
NPBC
| $7.34M | 0.02% |
650,311
-160,885
| -20% | -$1.74M |
|
|
LINE
902
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
| $7.33M | 0.02% |
822,968
+129,712
| +19% | +$1.52M |
|
903
John Wiley & Sons Class A
WLY
$2.52B
| $7.33M | 0.02% |
134,776
+113,471
| +533% | +$6.59M |
|
904
California Water Service
CWT
$3.04B
| $7.3M | 0.02% |
319,380
-9,055
| -3% | -$217K |
|
|
WNS
905
DELISTED
WNS Holdings
WNS
| $7.29M | 0.02% |
272,557
+126,971
| +87% | +$3.26M |
|
906
Invesco Senior Loan ETF
BKLN
$7.1B
| $7.26M | 0.02% |
305,232
+3,032
| +1% | +$73K |
|
907
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
| $7.26M | 0.02% |
137,800
+1,816
| +1% | +$95.7K |
|
|
SIR
908
DELISTED
SELECT INCOME REIT
SIR
| $7.25M | 0.02% |
798,793
-203,959
| -20% | -$2.09M |
|
|
EEP
909
DELISTED
Enbridge Energy Partners
EEP
| $7.25M | 0.02% |
217,400
+53,539
| +33% | +$1.97M |
|
910
Kirby Corp
KEX
$7.95B
| $7.23M | 0.02% |
94,301
+31,089
| +49% | +$2.46M |
|
911
AB InBev
BUD
$158B
| $7.22M | 0.02% |
59,799
-4,598
| -7% | -$564K |
|
912
NewMarket
NEU
$7.17B
| $7.21M | 0.02% |
16,236
+13,340
| +461% | +$6.14M |
|
913
Crown Castle
CCI
$32.7B
| $7.18M | 0.02% |
89,412
+69,818
| +356% | +$5.83M |
|
|
LGF
914
DELISTED
Lions Gate Entertainment
LGF
| $7.17M | 0.02% |
+193,527
| New | +$6.46M |
|
|
WCC
915
WESCO International
WCC
$16.2B
| $7.17M | 0.02% |
104,385
+23,735
| +29% | +$1.7M |
|
916
Erie Indemnity
ERIE
$11.7B
| $7.15M | 0.02% |
87,097
+8,430
| +11% | +$698K |
|
917
Sanofi
SNY
$104B
| $7.11M | 0.02% |
143,593
+3,091
| +2% | +$157K |
|
|
ESL
918
DELISTED
Esterline Technologies
ESL
| $7.11M | 0.02% |
74,554
-19,511
| -21% | -$2.09M |
|
919
GSK
GSK
$103B
| $7.1M | 0.02% |
136,365
+24,634
| +22% | +$1.39M |
|
|
BPL
920
DELISTED
Buckeye Partners, L.P.
BPL
| $7.09M | 0.02% |
95,966
+4,274
| +5% | +$335K |
|
921
EnerSys
ENS
$6.95B
| $7.09M | 0.02% |
100,854
-839
| -0.8% | -$57.6K |
|
922
Hancock Whitney
HWC
$6.13B
| $7.06M | 0.02% |
221,280
-31,390
| -12% | -$952K |
|
923
Sabesp
SBS
$19.7B
| $7.05M | 0.02% |
7,019,584
+812,240
| +13% | +$914K |
|
924
HNI Corp
HNI
$3B
| $7.05M | 0.02% |
137,843
+11,431
| +9% | +$590K |
|
|
PTR
925
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $7.01M | 0.02% |
63,308
+48,117
| +317% | +$5.86M |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.